Study of severe tissue infections
Part of Infections, Kidney & urinary clinical trials.
This trial studies a rare but serious infection called necrotizing soft-tissue infection (NSTI), which destroys tissue quickly. It looks at how patients are treated in hospitals across Europe to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed necrotizing soft-tissue infection (a fast-spreading, deep infection that destroys tissue) – proven by surgery, a tissue sample, or an imaging scan showing gas in the infection area.
- You are currently being treated at a hospital that is part of this trial.
- Your infection is not a mild or non-severe skin infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors are linked to higher risk of death in patients hospitalized with a severe, flesh-eating infection called necrotizing soft tissue infection (NSTI). It aims to help doctors better identify and treat these dangerous infections.
This trial tests whether adding hyperbaric oxygen therapy to standard care helps adults with a serious soft-tissue infection. It could improve healing and reduce complications.
This study compares a shorter course (about 7 days) of antibiotics to a longer course (about 14 days) for people who had surgery for a severe skin and muscle infection. The goal is to see if a shorter treatment works just as well.
This study tests two special wound dressings (Cytal® Wound Matrix and MicroMatrix®) to help heal wounds caused by a serious flesh-eating infection called necrotizing fasciitis. The goal is to see if these dressings improve healing and reduce the need for more surgeries.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
Hear when a new Necrotizing Soft Tissue Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.